Gland Pharma Limited (GLAND.BO)
INR 1479.45
(2.02%)
INR 1479.45
(2.02%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.37 Billion INR | -12.92% |
| 2022 | 19.06 Billion INR | -16.2% |
| 2021 | 22.74 Billion INR | 17.76% |
| 2020 | 19.31 Billion INR | 31.43% |
| 2019 | 14.69 Billion INR | 29.37% |
| 2018 | 11.36 Billion INR | 23.58% |
| 2017 | 9.19 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.43 Billion INR | -21.22% |
| 2024 Q2 | 3.61 Billion INR | 5.22% |
| 2023 Q2 | 8.51 Billion INR | 12.71% |
| 2023 FY | 16.6 Billion INR | -12.92% |
| 2023 Q4 | 4.35 Billion INR | -53.91% |
| 2023 Q3 | 9.45 Billion INR | 11.04% |
| 2023 Q1 | 7.55 Billion INR | 95.08% |
| 2022 Q4 | 3.87 Billion INR | -24.21% |
| 2022 Q3 | 5.11 Billion INR | -2.61% |
| 2022 Q2 | 5.24 Billion INR | 8.72% |
| 2022 FY | 19.06 Billion INR | -16.2% |
| 2022 Q1 | 4.82 Billion INR | -10.78% |
| 2021 Q3 | 5.59 Billion INR | 0.62% |
| 2021 Q1 | 6.17 Billion INR | 35.11% |
| 2021 Q2 | 5.56 Billion INR | -9.87% |
| 2021 FY | 22.74 Billion INR | 17.76% |
| 2021 Q4 | 5.41 Billion INR | -3.35% |
| 2020 Q1 | 5.64 Billion INR | 77.31% |
| 2020 Q4 | 4.56 Billion INR | 0.97% |
| 2020 Q3 | 4.52 Billion INR | -1.19% |
| 2020 Q2 | 4.57 Billion INR | -18.83% |
| 2020 FY | 19.31 Billion INR | 31.43% |
| 2019 Q3 | 3.68 Billion INR | 0.0% |
| 2019 Q4 | 3.18 Billion INR | -13.64% |
| 2019 Q1 | 3.88 Billion INR | 0.0% |
| 2019 FY | 14.69 Billion INR | 29.37% |
| 2018 FY | 11.36 Billion INR | 23.58% |
| 2017 FY | 9.19 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott India Limited | 26.16 Billion INR | 37.43% |
| Cipla Limited | 161.81 Billion INR | 89.882% |
| GlaxoSmithKline Pharmaceuticals Limited | 12.82 Billion INR | -27.705% |
| Kopran Limited | 1.47 Billion INR | -1010.103% |
| Marksans Pharma Limited | 7.71 Billion INR | -112.244% |
| NGL Fine-Chem Limited | 1.23 Billion INR | -1228.422% |
| Pfizer Limited | 9.9 Billion INR | -65.286% |
| Sanofi India Limited | 15.93 Billion INR | -2.729% |
| SMS Pharmaceuticals Limited | 2.08 Billion INR | -684.29% |